CG Oncology, Inc. Contracts & Agreements
27 Contracts & Agreements
- Business Finance (7 contracts)
- Business Operations (3)
- Human Resources (15)
- Intellectual Property (1)
- Uncategorized (1)
- Form of Underwriting Agreement (Filed With SEC on December 11, 2024)
- Description of Registered Securities (Filed With SEC on March 26, 2024)
- Employment Agreement, effective January 16, 2024, between Corleen Roche and the Registrant (Filed With SEC on January 18, 2024)
- Non-Employee Director Compensation Program (Filed With SEC on January 18, 2024)
- CG Oncology, Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on January 18, 2024)
- CG Oncology, Inc. 2024 Incentive Award Plan and form of stock option agreement and form of restricted stock unit agreement thereunder (Filed With SEC on January 18, 2024)
- Amended and Restated Investors Rights Agreement, dated July 28, 2023, as amended, by and among the Registrant and certain of its stockholders (Filed With SEC on January 18, 2024)
- Specimen stock certificate evidencing the shares of common stock (Filed With SEC on January 18, 2024)
- Form of Underwriting Agreement (Filed With SEC on January 18, 2024)
- Amended and Restated Employment Agreement, effective December 13, 2023, between Arthur Kuan and the Registrant (Filed With SEC on January 2, 2024)
- Amended and Restated Employment Agreement, effective December 13, 2023, between Vijay Kasturi and the Registrant (Filed With SEC on January 2, 2024)
- Employment Agreement, effective August 14, 2023, between Vijay Kasturi and the Registrant (Filed With SEC on January 2, 2024)
- Amended and Restated Employment Agreement, effective December 13, 2023, between Ambaw Bellete and the Registrant (Filed With SEC on January 2, 2024)
- Employment Agreement, effective July 9, 2023, between Ambaw Bellete and the Registrant (Filed With SEC on January 2, 2024)
- Amended and Restated Investors Rights Agreement, dated July 28, 2023, by and among the Registrant and certain of its stockholders (Filed With SEC on January 2, 2024)
- Amended and Restated Employment Agreement, effective March 15, 2023, between Arthur Kuan and the Registrant (Filed With SEC on January 2, 2024)
- Annual Bonus Plan (Filed With SEC on January 2, 2024)
- Policy for the Recovery of Erroneously Awarded Compensation (Filed With SEC on January 2, 2024)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on January 2, 2024)
- First Amendment to the License and Collaboration Agreement, dated September 15, 2022, between Kissei Pharmaceutical Co., Ltd. and the Registrant (Filed With SEC on January 2, 2024)
- License and Collaboration Agreement, dated March 26, 2020, between Kissei Pharmaceutical Co., Ltd. and the Registrant (Filed With SEC on January 2, 2024)
- Development and License Agreement, dated March 11, 2019, between the Lepu Biotech Co., Ltd. and the Registrant (Filed With SEC on January 2, 2024)
- Non-Employee Director Compensation Program (Filed With SEC on January 2, 2024)
- CG Oncology, Inc. 2024 Employee Stock Purchase Plan (Filed With SEC on January 2, 2024)
- CG Oncology, Inc. 2024 Incentive Award Plan and form of stock option agreement and form of restricted stock unit agreement thereunder (Filed With SEC on January 2, 2024)
- CG Oncology, Inc. 2022 Incentive Award Plan and form of stock option agreement, form of stock option agreement (early exercise) and form of restricted stock unit agreement... (Filed With SEC on January 2, 2024)
- CG Oncology, Inc. 2015 Equity Incentive Plan, as amended, and form of stock grant agreement and form of stock option agreement thereunder (Filed With SEC on January 2, 2024)
